S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
Log in
NASDAQ:ICPT

Intercept Pharmaceuticals Price Target, Predictions & Analyst Ratings

$20.66
+1.33 (+6.88 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$18.15
Now: $20.66
$20.66
50-Day Range
$19.33
MA: $30.35
$37.75
52-Week Range
$18.15
Now: $20.66
$95.98
Volume1.66 million shs
Average Volume1.16 million shs
Market Capitalization$682.11 million
P/E RatioN/A
Dividend YieldN/A
Beta1.85

Analyst Ratings

Intercept Pharmaceuticals (NASDAQ:ICPT) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
24 Wall Street analysts have issued ratings and price targets for Intercept Pharmaceuticals in the last 12 months. Their average twelve-month price target is $50.87, predicting that the stock has a possible upside of 146.22%. The high price target for ICPT is $88.00 and the low price target for ICPT is $25.00. There are currently 2 sell ratings, 14 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
ICPT Consensus Rating: HoldHoldHoldHold
ICPT Consensus Rating Score: 2.252.292.352.29
ICPT Analyst Ratings: 2 Sell Rating(s)
14 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
15 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
15 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
17 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
ICPT Consensus Price Target: $50.87$58.74$65.41$75.61
ICPT Price Target Upside: 146.22% upside34.63% upside35.54% upside37.67% upside

Intercept Pharmaceuticals (NASDAQ:ICPT) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Intercept Pharmaceuticals (NASDAQ:ICPT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/4/2021Raymond JamesLower Price TargetOutperform$60.00 ➝ $52.00N/A
3/2/2021Needham & Company LLCLower Price TargetBuy$80.00 ➝ $34.00Medium
3/1/2021WedbushLower Price TargetOutperform$106.00 ➝ $88.00Low
3/1/2021B. RileyLower Price TargetBuy$74.00 ➝ $65.00Low
3/1/2021HC WainwrightReiterated RatingNeutral ➝ Sell$25.00Low
3/1/2021Chardan CapitalLower Price TargetBuy$58.00 ➝ $45.00Low
1/15/2021Bank of AmericaDowngradeNeutral ➝ Underperform$40.00 ➝ $27.00High
12/21/2020Jefferies Financial GroupDowngradeBuy ➝ Hold$30.00Low
11/11/2020Canaccord GenuityBoost Price TargetHold$42.00 ➝ $58.00Medium
11/10/2020BMO Capital MarketsLower Price TargetMarket Perform$56.00 ➝ $38.00High
11/10/2020Royal Bank of CanadaLower Price TargetSector Perform$49.00 ➝ $40.00High
11/10/2020Credit Suisse GroupLower Price TargetHold ➝ Neutral$60.00 ➝ $42.00High
11/10/2020Robert W. BairdUpgradeNeutral ➝ Outperform$52.00High
11/10/2020SVB LeerinkLower Price TargetMarket Perform$50.00 ➝ $48.00High
8/11/2020OppenheimerReiterated RatingHold$54.00Medium
8/10/2020Stifel NicolausBoost Price TargetHold$51.00 ➝ $56.00High
7/30/2020Piper SandlerInitiated CoverageOverweight$82.00Medium
7/21/2020JMP SecuritiesDowngradeOutperform ➝ Market PerformLow
6/30/2020CitigroupUpgradeNeutral ➝ Buy$110.00 ➝ $67.00High
6/30/2020UBS GroupDowngradeBuy ➝ Neutral$135.00 ➝ $57.00Medium
6/30/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral$57.00Medium
6/29/2020CowenDowngradeOutperform ➝ Market Perform$149.00 ➝ $47.00Medium
6/29/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$150.00 ➝ $60.00High
6/29/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$146.00 ➝ $46.00High
1/14/2019LaidlawUpgradeHold ➝ Buy$99.00 ➝ $130.00Low
11/19/2018CIBCUpgradeMarket Perform ➝ OutperformMedium
9/12/2018Roth CapitalInitiated CoverageBuy ➝ Buy$192.00Low
(Data available from 3/6/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.